The Journal of Immunology, Vol 157, Issue 8 3510-3517, Copyright © 1996 by American Association of Immunologists

ARTICLES

Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region

DJ Zhang, VK Tsiagbe, C Huang and GJ Thorbecke
Department of Pathology and Kaplan Cancer Center, New York University School of Medicine, NY 10016, USA.

SJL mouse lymphomas (reticulum cell sarcomas, or RCSs) of germinal center B cell origin express an endogenous mouse mammary tumor virus (mtv-29) superantigen (vSAg) that stimulates Vbeta16+ T cells to produce cytokines essential for RCS growth. Normal or LPS-activated SJL/J B cells contain two to three larger mRNAs for mouse mammary tumor virus-long terminal repeat (LTR) but not the 1.8-kb mRNA, which is prominent in RCS cells and encodes the vSAg-29. mRNAs from RCS and normal lymphoid cells were characterized by Northern hybridization using DNA probes from various regions of mtv-29, as well as by reverse transcription PCR, RNase protection, and primer extension. The larger mtv-29 transcripts, coding for envelope protein, are initiated in the 5' LTR, as expected. Surprisingly, the 1.8-kb mRNA, encoding the open reading frame of the LTR, is initiated in the middle of the env region and spliced in the 3' env. This is the first report of an mtv-vSAg transcript that is not controlled by promoter(s) located in the 5' LTR. The env initiation site appears identical to that of the mouse mammary tumor virus env transcriptional activator-directed PMA-induced defective LTR transcript in the C57BL6 T cell lymphoma, EL-4. The stimulus independence, B lymphoma specificity, and absence of deletions within either the 5' or 3' LTR regions of mtv-29 in RCS distinguish the situation in RCS cells from that in EL-4. These findings suggest that the novel mtv-29-vSAg transcript reflects an RCS-cell-specific regulation of transcription.

This article has been cited by other articles:

				R. M. Thomas, K. Haleem, A. B. Siddique, W. J. Simmons, N. Sen, D.-J. Zhang, and V. K. Tsiagbe Regulation of Mouse Mammary Tumor Virus env Transcriptional Activator Initiated Mammary Tumor Virus Superantigen Transcripts in Lymphomas of SJL/J Mice: Role of Ikaros, Demethylation, and Chromatin Structural Change in the Transcriptional Activation of Mammary Tumor Virus Superantigen J. Immunol., January 1, 2003; 170(1): 218 - 227. [Abstract] [Full Text] [PDF]

				N. M. Ponzio G. Jeanette Thorbecke, 1929-2001 Am. J. Pathol., June 1, 2002; 160(6): 1917 - 1920. [Full Text] [PDF]

				N. Sen, W. J. Simmons, R. M. Thomas, G. Erianne, D.-J. Zhang, N. S. Jaeggli, C. Huang, X. Xiong, V. K. Tsiagbe, N. M. Ponzio, et al. META-Controlled env-Initiated Transcripts Encoding Superantigens of Murine Mtv29 and Mtv7 and Their Possible Role in B Cell Lymphomagenesis J. Immunol., May 1, 2001; 166(9): 5422 - 5429. [Abstract] [Full Text] [PDF]

				K. Aurrekoetxea-Hernández and E. Buetti Synergistic Action of GA-Binding Protein and Glucocorticoid Receptor in Transcription from the Mouse Mammary Tumor Virus Promoter J. Virol., June 1, 2000; 74(11): 4988 - 4998. [Abstract] [Full Text]

				B. Salmons, T. Miethke, S. Wintersperger, M. Müller, G. Brem, and W. H. Günzburg Superantigen Expression Is Driven by Both Mouse Mammary Tumor Virus Long Terminal Repeat-Associated Promoters in Transgenic Mice J. Virol., March 15, 2000; 74(6): 2900 - 2902. [Abstract] [Full Text]

				L. Z. Chen, G. M. Hochwald, C. Huang, G. Dakin, H. Tao, C. Cheng, W. J. Simmons, G. Dranoff, and G. J. Thorbecke Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta 1 PNAS, October 13, 1998; 95(21): 12516 - 12521. [Abstract] [Full Text] [PDF]

				F. U. Reuss and J. M. Coffin Mouse Mammary Tumor Virus Superantigen Expression in B Cells Is Regulated by a Central Enhancer within the pol Gene J. Virol., July 1, 1998; 72(7): 6073 - 6082. [Abstract] [Full Text] [PDF]